Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.

BACKGROUND Patients with prior coronary bypass surgery with acute ST-segment elevation myocardial infarction (MI) pose an increasingly common clinical problem. We assessed the characteristics and outcomes of such patients undergoing thrombolysis for acute MI. METHODS AND RESULTS We compared the characteristics and outcomes of patients in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial (GUSTO-I) who had had prior bypass (n = 1784, 4% of the population) with those without prior coronary artery bypass grafting (CABG), all of whom were randomized to receive one of four thrombolytic strategies. Patients with prior bypass were older with significantly more prior MI and angina. Overall, 30-day mortality was significantly higher in patients with prior bypass (10.7% vs 6.7% for no prior bypass, P <.001); these patients also had significantly more pulmonary edema, sustained hypotension, or cardiogenic shock. Patients with prior bypass showed a 12.5% relative reduction (95% confidence interval, 0% to 41.9%) in 30-day mortality with accelerated alteplase over the streptokinase monotherapies. In the 62% of patients with prior CABG who underwent coronary angiography, the infarct-related vessel was a native coronary artery in 61.9% and a bypass graft in 38.1% of cases. The Thrombolysis in Myocardial Infarction (TIMI) 3 flow rate was 30.5% for culprit native coronary arteries and 31.7% for culprit bypass grafts. Patients with prior bypass had more severe infarct-vessel stenoses (99% [90%, 100%] vs 90% [80%, 99%], P <.001). CONCLUSIONS The 30-day mortality in patients with prior CABG was significantly higher than that for patients without prior CABG. As in the overall trial, these patients derived an incremental survival benefit from treatment with accelerated alteplase, but mortality remained high (16.7%) at 1 year. These results are at least partially explained by the higher baseline risk of these patients and by the lower rate of patency of the infarct-related artery.

[1]  K. Lee,et al.  Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. , 2000, Circulation.

[2]  Regina M. Hardison,et al.  The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. , 2000, The New England journal of medicine.

[3]  J. J. Griffin,et al.  Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction , 2000 .

[4]  W. Weaver,et al.  Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2). , 1999, The American journal of cardiology.

[5]  W. O’Neill,et al.  Prospective study of extraction atherectomy in patients with acute myocardial infarction. , 1996, The American journal of cardiology.

[6]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[7]  J. O’Keefe,et al.  Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. , 1993, The American journal of cardiology.

[8]  Gusto Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[9]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[10]  J. W. Kennedy,et al.  Early Mortality of Acute Myocardial Infarction in Patients With and Without Prior Coronary Revascularization Surgery: A Coronary Artery Surgery Study Registry Study , 1992, Circulation.

[11]  K. Lee,et al.  Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee. , 1992, Journal of the American College of Cardiology.

[12]  P. Peduzzi,et al.  Ten‐Year Incidence of Myocardial Infarction and Prognosis After Infarction: Department of Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery , 1991, Circulation.

[13]  A. DeMaria,et al.  Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. , 1990, The American journal of cardiology.

[14]  E. Topol,et al.  Acute intervention during myocardial infarction in patients with prior coronary bypass surgery. , 1990, The American journal of cardiology.

[15]  B. Rutherford,et al.  Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting. , 1990, The American journal of cardiology.

[16]  N. Kleiman,et al.  Early intravenous thrombolytic therapy for acute myocardial infarction in patients with prior coronary artery bypass grafts. , 1989, The American journal of cardiology.

[17]  K. Kayser,et al.  Angina pectoris and coronary bypass surgery: patterns of prevalence and recurrence in 3105 consecutive patients followed up to 11 years. , 1984, American heart journal.

[18]  F. Loop,et al.  Trends in selection and results of coronary artery reoperations. , 1983, The Annals of thoracic surgery.

[19]  M. Bourassa,et al.  Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. , 1983, Circulation.

[20]  M. Bourassa,et al.  Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. , 1979, Circulation.

[21]  G. E. Green,et al.  Aortocoronary bypass surgery: a 7-year follow-up. , 1979, Circulation.